KE

Unknown

871 clinical trials

Find Trials

Clinical Trials (871)

Showing 20 of 871 trialsScroll for more
NCT05609786Not Applicable1 site

Dissemination and Implementation of a Web-based Relationship Safety App, myPlanKenya, for Women at Risk for Intimate Partner Violence in Nairobi, Kenya

Completed
NCT06134362Phase 31 site

Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure Prophylaxis) in Participants at Risk of Acquiring HIV (Human Immunodeficiency Virus)

Active Not Recruiting
NCT06790342Phase 32 sites

Optimizing Treatment of Co-occurring Smoking and Unhealthy Alcohol Use Among PWH in Nairobi, Kenya

Not Yet Recruiting
NCT06623994Not Applicable1 site

Bridging the Treatment Gap by Expanding Access to Care for People With Epilepsy in Kenya (BEACON)

Recruiting
NCT07734727Not Applicable1 site

Adaptation and Testing of a Novel Text-based Tobacco Cessation and Education Intervention in Kenyan Emergency Department Patients

Not Yet Recruiting
NCT06501885Not Applicable1 site

PrEP (Pre-exposure Prophylaxis) Stigma and Women Ethnodrama Pre-Test Phase

Completed
NCT07225894Not Applicable1 site

PrEP (Pre-exposure Prophylaxis) Stigma and Women Ethnodrama Pilot Phase

Completed
NCT05894239Phase 31 site

A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer

Recruiting
NCT05666778Phase 21 site

Single Arm Trial of Menstrual Cups Among Economically Vulnerable Women to Reduce Bacterial Vaginosis and STIs

Active Not Recruiting
NCT06439082Phase 34 sites

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

Recruiting
NCT02591420Phase 11 site

Safety and Virologic Effect of a Human Monoclonal Antibody (VRC01) Administered Intravenously to Adults During Early Acute HIV Infection

Completed
NCT04543617Phase 32 sites

A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy

Active Not Recruiting

Treatment Outcomes of Esophageal Cancer

Recruiting

iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases

Recruiting
NCT07076043Phase 41 site

Multi-product PrEP Delivery to Young Women Seeking Reproductive Health Services and Coverage of HIV Prevention

Recruiting

A Study to Characterize the Clinical Presentation and Course of Cryptosporidium in Pediatric Participants

Recruiting
NCT02140255Phase 11 site

Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission

Recruiting
NCT06192160Phase 22 sites

Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis

Recruiting
NCT07044297Phase 33 sites

A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)

Recruiting
NCT07071623Phase 34 sites

A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)

Recruiting